The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, which refers to breathing interrupted during sleep due to narrowed or blocked airways
In the treatment of allergic rhinitis and other upper respiratory diseases, nasal drug administration can target the affected site directly, minimise systemic side effects, and offer improved symptomatic relief (Sun et al., 2019), intranasal administration allows drugs to be absorbed and transported to the brain, a process mediated by two primary pathways
Reimbursement rates range from approximately $3 to $40 per injection administration depending on the state fee schedule
B12 deficiency prevention during GLP-1 therapy This is the more serious reason for B12 inclusion, and it is one that many patients are not informed about
Honest Pricing, Same Price at Every Dose
For telehealth operators, audit your marketing claims